Zenith Drugs Limited — Others, 13-01-2025: Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

Zenith Drugs Limited has announced a board meeting to discuss its non-applicability of the Corporate Governance Regulation, as it qualifies under SEBI's criteria for exemption due to its paid-up equity share capital not exceeding ₹10 crore and net worth below ₹25 crore. As a result, the company is not required to submit a Corporate Governance Report for the quarter ended 31st December 2024. This exemption could reduce administrative burdens, potentially allowing management to focus resources on core operations. Investors may view this as a neutral impact, although it highlights the company's current size and growth stage.